Evidence map›Paper›PMID 37543915›Full record

ArticleArchives of Iranian medicine2023

Uterine and Cervical Cancer in Iran: An epidemiologic analysis of the Iranian National Population-Based Cancer Registry.

Hani AziziKia, Hamidreza Didar, Azin Teymourzadeh, Amin Nakhostin-Ansari, Pooya Jafari Doudaran, Bahareh Farasati Far, Armin Hoveidaei, Gholamreza Roshandel

Open access · greenAbstract read
In one paragraph

Article in Archives of Iranian medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Hani AziziKiaStudent Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.ORCID 0009-0007-1080-4570
Hamidreza DidarPreventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Azin TeymourzadehImam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Amin Nakhostin-AnsariSports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Pooya Jafari DoudaranFaculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
Bahareh Farasati FarDepartment of Chemistry, Iran University of Science and Technology, Tehran, Iran.
Armin HoveidaeiBSc in Radiotherapy Technology, Student Research Committee, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gholamreza RoshandelGolestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.ORCID 0000-0002-5494-0722
Shahid Beheshti University of Medical Sciences · IRGolestan University · IRImam Khomeini Hospital · IRIran University of Science and Technology · IRQom University of Medical Science and Health Services · IRShahroud University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGynecologic cancers, including neoplasms of the cervix and uterine, are the fourth most common malignancies, causing 3.46% of deaths in women aged 15 to 59.

objectivesWe aimed to report the Iranian National Population-based Cancer Registry (INPCR) results for Cervical and Uterine cancers in 2017.

methodsThe total population of Iran in 2017 was 80881792. INPCR collected data on cervical and uterine cancer incidence from 31 provinces of Iran. In this project, we retrospectively examined all the country's regions in terms of screening for the existence of these two cancers. The registry data bank in Iran was used.

resultsOverall, 3481 new cervical and uterine cancer cases were registered in INPCR, including 842 cases of cervical cancer (with a crude rate of 1.04) and 2639 cases of uterine cancer (with a crude rate of 3.26). The average age-standardized incidence rate (ASR) was 0.99 for cervical cancer and 3.29 for uterine cancer. Out of 3481 new cervical and uterine cancer cases, 2887 were registered with pathological findings and 594 without pathological confirmation. In cervical cancers, the highest rate was related to squamous cell carcinoma, with 486 cases (57.72%).

conclusionOur results showed that Iran is a low-risk area for the incidence of cervical and uterine cancers. In this study, the highest rate of cervical cancer was related to squamous cell carcinoma, confirming previous reports. However, this rate was lower than previous studies and suggested an increase in other types of cervical cancer in Iran.

Indexed as

Carcinoma, Squamous CellUterine Cervical NeoplasmsUterine NeoplasmsFemaleHumansIncidenceIranRegistriesRetrospective StudiesEpidemiologyUterine cervical neoplasmsUterine neoplasms

Identifiers

PMID37543915
PMCPMC10685806
OpenAlexW4380343374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.